Tauto-an, Teresita B.

HRN: 20-36-59  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2022
CEFTRIAXONE 1G (VIAL)
05/08/2022
05/14/2022
IV
2gm
Q24
CAP MR
Waiting Final Action 
05/10/2022
AZITHROMYCIN 500MG TABLET (TAB)
05/10/2022
05/14/2022
PO
500mgtab
OD
CAP MR
Waiting Final Action 
06/08/2022
CEFTRIAXONE 1G (VIAL)
06/08/2022
06/14/2022
IV
2gm
OD
CAP MR
Waiting Final Action 
06/08/2022
AZITHROMYCIN 500MG TABLET (TAB)
06/08/2022
06/12/2022
PO
500mg
OD
CAP MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: